Psilocybin-assisted group therapy: A new hope for demoralization [PDF]
Peter S. Hendricks
doaj +3 more sources
Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial [PDF]
Background Psilocybin-assisted therapy (PAT) shows promise for treating PTSD in adults but hasn’t been studied in U.S. military Veterans, who face higher symptom severity and suicide risk.
Stacey B. Armstrong +7 more
doaj +2 more sources
Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trial [PDF]
Background A significant number of individuals with alcohol use disorder remain unresponsive to currently available treatments, which calls for the development of new alternatives.
Laetitia Vanderijst +12 more
doaj +2 more sources
Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery [PDF]
Background: Psychedelics are receiving growing interest among clinical researchers for their effects on mood and cognition. Psilocybin is one of the most widely studied classic psychedelics which has shown good safety and clinical benefit for major ...
Baeleigh VanderZwaag +2 more
doaj +2 more sources
Fungi for the Mind: Exploring the role of suggestion in psilocybin assisted therapy
This thesis explores the intersection of suggestion and psychedelic-assisted therapy (PAT), focusing specifically on the therapeutic use of psilocybin.
Clare, Susan
core +6 more sources
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder. [PDF]
We examined if the therapeutic alliance between study participants and intervention facilitators in a psilocybin-assisted therapy (PAT) trial changed over time and whether there were relationships between alliance, acute psilocybin experiences, and ...
Adam W Levin +8 more
doaj +2 more sources
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder [PDF]
Major depressive disorder (MDD) is a substantial public health burden, but current treatments have limited effectiveness and adherence. Recent evidence suggests that 1 or 2 administrations of psilocybin with psychological support produces antidepressant effects in patients with cancer and in those with treatment-resistant depression.To investigate the ...
Davis, Alan K. +7 more
openaire +2 more sources
Exploring the relationship between mental health, drug use, personality, and attitudes towards psilocybin-assisted therapy [PDF]
Background: Psilocybin, the psychoactive compound in magic mushrooms, is increasingly discussed in terms of its psychotherapeutic potential; however, little is known about community attitudes towards psilocybin assisted therapy (PAT).
Benjamin M. Ross +3 more
core +1 more source
Group psychedelic therapy: empirical estimates of cost-savings and improved access
ObjectiveTo compare group and individual psychedelic-assisted therapy in terms of clinician time, costs and patient access.MethodsUsing 2023 data from two group therapy trial sites, one using 3,4-Methylenedioxymethamphetamine (MDMA) to treat ...
Elliot Marseille +7 more
doaj +1 more source
The Yale Manual for Psilocybin-Assisted Therapy of Depression provides researchers and therapists with methods, structure, and areas to consider regarding the use of psychedelic- assisted therapy in the treatment of Major Depressive Disorder (MDD).
Jeffrey Guss +4 more
core +1 more source

